Technical Analysis for LUNG - Pulmonx Corporation

Grade Last Price % Change Price Change
grade D 42.44 -1.44% -0.62
LUNG closed down 1.44 percent on Friday, October 23, 2020, on approximately normal volume.
Earnings due: Nov 10
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical LUNG trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Down 3 Days in a Row Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup -1.44%
NR7 Range Contraction -1.44%
Bearish Engulfing Bearish -3.33%
New 52 Week Closing High Bullish -12.94%
Up 3 Days in a Row Strength -12.94%
Up 4 Days in a Row Strength -12.94%
Up 5 Days in a Row Strength -12.94%
New 52 Week Closing High Bullish -10.24%
Older End-of-Day Gignals for LUNG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 2 days ago
Down 3% 2 days ago
Down 2 % 2 days ago
Down 1% 2 days ago
Up 1% 2 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.

Is LUNG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 52.0
52 Week Low 37.64
Average Volume 273,059
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 43.78
Average True Range 4.20
ADX 0.0
+DI 23.97
-DI 16.52
Chandelier Exit (Long, 3 ATRs ) 39.39
Chandelier Exit (Short, 3 ATRs ) 50.25
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.26
MACD Signal Line 0.32
MACD Histogram -0.0663
Fundamentals Value
Market Cap 1.3 Billion
Num Shares 30.7 Million
EPS
Price-to-Sales 25.02
Price-to-Book 42.80
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.17
Resistance 3 (R3) 47.03 45.33 46.38
Resistance 2 (R2) 45.33 44.12 45.39 46.11
Resistance 1 (R1) 43.88 43.38 43.03 44.02 45.85
Pivot Point 42.18 42.18 41.75 42.24 42.18
Support 1 (S1) 40.73 40.97 39.88 40.87 39.03
Support 2 (S2) 39.03 40.23 39.09 38.77
Support 3 (S3) 37.58 39.03 38.50
Support 4 (S4) 37.72